Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additives to bupivacaine in ultrasound-guided erector spinae plane block for pediatric inguinal hernia repair
PACTR202306690104069Phase 4Recruiting
- Sponsor
- Faculty of medicine
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in inguinal hernia and postoperative pain comparing Plain bupivacaine ESP block, Bupivacaine plus magnesium sulfate ESP block and Bupivacaine plus dexamethasone ESP block (3 arms). Primary endpoints: Postoperative pain score, Time to first rescue paracetamol and 2 more. Started Feb 2022; status: recruiting.
02
Drugs
bupivacainemagnesium sulfatedexamethasone
03
Conditions
inguinal herniapostoperative pain
Beyond the preview
Go deeper on PACTR202306690104069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306690104069.